Introduction
Since 1984, in an attempt to maintain at least part of the splenic function when the removal of the spleen is recommended, we have performed subtotal splenectomies, preserving the superior splenic pole supplied by the splenogastric vessels. This procedure was successfully used for the treatment of 130 patients with portal hypertension, 93 patients with severe splenic trauma, 18 patients with myeloid metaplasia, nine patients with Gaucher's disease, five patients with retarded growth and sexual development associated with splenomegaly, five patients with chronic lymphocytic leukemia, three patients with severe splenic pain due to intraparenchymal thrombosis, one patient with splenic hemangioma, one patient with splenic abscess, and one patient with a cystadenoma of the pancreatic tail [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] .
Splenectomy has a very limited role in the treatment of Hodgkin's lymphoma (HL) and is recommended only to control HL activity that does not respond to chemo-and radiotherapy [16, 17] . Since the purpose of a splenectomy is not to make the patient asplenic, a partial splenectomy may achieve the objectives without the adverse side effects of the total removal of the spleen [18] [19] [20] . This is the first report of subtotal splenectomy preserving the infe- * Correspondence to: Avenida Afonso Pena, 1626 -apto. 1901, Belo Horizonte, MG 30130-005, Brazil.
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Presentation of case
The treatment performed on this patient was approved by the Ethical Committee of the Federal University of Minas Gerais under the Protocol nr. CAAE 03990.203.000-11 and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The patient had consent the publication of this case report. This work has been reported in line with the SCARE criteria [21] .
A 53-year-old white man with HL was submitted to chemotherapy and radiotherapy at Hospital of Clinics of the Federal University of Minas Gerais, Brazil and referred to the Department of Surgery for splenectomy. The indications for spleen removal were abdominal and breathing discomfort caused by a huge spleen due to HL refractory to adjuvant oncologic therapy. To avoid surgical induced asplenic immune depression, a subtotal splenectomy was recommended.
The abdominal cavity was entered through a left transverse laparotomy; the splenic artery was tied in the retrogastric space. At laparotomy, a very large spleen with a tumor restricted to the superior pole was found (Fig. 1A) . The spleen was displaced upward, and its ligaments were sectioned. The superior splenic vessels, including the splenogastric vessels, the superior splenic pole vessels and the splenic hilum were tied and cut. Care was taken to preserve the left gastroepiploic and the inferior splenic pole vessels to maintain A-The very large spleen mobilized within the surgical field after the section of the splenic ligaments. Observe the tumor in the superior pole (*) and the transition (arrow) between the inferior pole (red) supplied by the left gastroepiploic and inferior pole vessels and the rest of the devascularized spleen (dark color). B -The inferior splenic pole (*) after subtotal splenectomy. Observe the left gastroepiploic vessels (long thin arrow) inside the grater omentum, and the inferior pole vessels (short thick arrow).
the vitality of the inferior splenic pole. The spleen was cut at the dividing line between the normal color of the inferior portion of the organ and the darker colored superior portion (Fig. 1A) . Two wide flaps (anterior and posterior) of the 5 splenic capsule were retained. The bleeding large vessels of parenchyma were sutured with 4-0 chromic catgut. A continuous 3-0 chromic catgut suture closed the two flaps of the splenic capsule (Fig. 1B) . The inferior pole was returned to its normal position and sutured to the diaphragm with one stitch using 2-0 chromic catgut. The blood loss was minimal and no blood transfusion was necessary. The removed spleen weighed 2300 g.
Histopathological analyses of the spleen confirmed the HL restricted to the superior pole with wide margins free of tumor. The patient had uneventful postoperative recovery and was discharged from the hospital on the fifth postoperative day. During the eleven-year follow-up the patient presented no severe infection, and the lymphoma was adequately controlled. Scintigraphic images of the splenic remnant were positive in all postoperative exams, confirming the splenic vitality and the phagocytic function. The dimensions of the splenic remnant, according to CT exams, remained unchanged during the follow-up period (Table 1) .
Discussion
Chemo-and radiotherapy are the usual treatments of HL, and most of patients survive many years under control [16, 17] . How- ever, the huge growth of the spleen, which may occur in some patients, leads to abdominal discomfort and therapeutic resistance. It is well-known that total splenectomy reduces the immune defenses and may be followed by severe sepsis associated with precocious and sudden deaths. This complication is more frequent in previously immune suppressed patients, such as those with lymphomas [19, 20] . Chemo-and radiotherapy worsen organic defenses and enhance mortality. Since the total removal of the spleen is not necessary to treat HL, partial splenectomy should be enough to reduce the influence of splenic growth on both the symptoms and the hematologic system [18, 19] . However, the early good results are transitory, given that the spleen may regrow due to the blood flow through the splenic vascular pedicle [20] . To avoid this inconvenient follow-up, we have proposed the subtotal splenectomy, which preserves a pole of the spleen without the vascular pedicle. Usually, the subtotal splenectomy maintains only the superior pole supplied by the splenogastric vessels, but in this case, the tumor was located in the superior pole and had to be removed. Therefore, we decided to perform the subtotal splenectomy, preserving the inferior splenic pole supplied by the left gastroepiploic vessels. Prior to the present case report, the use of this technique had never been published. Thus, we decided to follow the patient a least for ten years before publishing the case to detect all complications of this procedure when in the presence of HL. Its main advantage is to preserve the splenic functions in a normal size spleen without the risk of its regrowth and resistance to oncologic treatment.
As limitation of this study, the lower number of patients with HL confined to a single pole must be emphasized. This procedure should not be attempted for staging purpose in HL because the disease may be present in the preserved spleen even without its macroscopic evidence. Further studies are needed to confirm the efficacy of this procedure in other case.
Conclusion
A subtotal splenectomy that preserves the inferior splenic pole is efficacious in maintaining splenic functions and preventing the adverse effects of a large spleen in the treatment of Hodgkin's lymphoma confined to superior pole and producing significant abdominal symptoms and hematological effects.
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